HopeStage
Back to all studies
CompletedNCT02299440

Ketamine for Short-Term Suicidal Thoughts

About this title

Effects of Ketamine in the Acute Phase of Suicidal Ideation

Read the official source — NCT02299440
Medication studyAges 18+FranceSuicide prevention
The study in practice

Understand this study

Who was this study for?

Listed age limits: from 18 years.

Listed locations
Clermont-Ferrand and 8 more locationsSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: April 2015
Recruitment status
Completed
Enrollment listed in the registry
156
Sponsor
Centre Hospitalier Universitaire de Nīmes
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug, Other
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
France
Age range
Over 18 Years
Official registry ID
NCT02299440
Official title
Show the full official title

Evaluation of the Effects of Ketamine in the Acute Phase of Suicidal Ideation: a Multicenter Randomized Double-blind Trial

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Clermont-Ferrand · Lille · Montpellier

3 more locations
  • Nîmes
  • Paris
  • Saint-Cyr-sur-Loire

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Centre Hospitalier Universitaire de Nīmes.

Did this study involve medication?

Yes. The study involved medication, including 1st perfusion of ketamine, 1st perfusion of saline, 2nd perfusion of ketamine and 2nd perfusion of saline.

Who was this study for?

Listed age limits: from 18 years.

Want to explore more studies?

Explore studies